The LRRC26 protein selectively alters the efficacy of BK channel activators

Janos Almassy1, Ted Begenisich

  • 1Department of Pharmacology and Physiology, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642, USA.

Molecular Pharmacology
|October 11, 2011
PubMed

Insights

Mallotoxin (MTX) activates large conductance calcium-activated potassium (BK) channels, but its effect is reduced by the accessory protein LRRC26 in native parotid cells. LRRC26 selectively alters BK channel pharmacology.

Area of Science:

  • Biophysics
  • Molecular Biology
  • Pharmacology

Background:

  • Large conductance, calcium-activated potassium (BK) channels are crucial for numerous physiological processes.
  • Mallotoxin (MTX) is a known potent activator of BK channels, significantly altering their voltage gating and activity.
  • Understanding BK channel pharmacology is vital due to their diverse physiological roles.

Purpose of the Study:

  • To investigate the differential effects of mallotoxin (MTX) on BK channels in native parotid acinar cells versus heterologously expressed channels.
  • To determine the role of the accessory protein LRRC26 in modulating the response of parotid BK channels to MTX and other activators.
  • To elucidate the selective pharmacological impact of LRRC26 on BK channel activation.

Main Methods:

  • Electrophysiological recordings (e.g., patch-clamp) to measure BK channel activity and gating kinetics.
  • Heterologous expression of BK channel isoforms (parSlo) with and without the LRRC26 accessory protein.
  • Application of pharmacological agents, including MTX and NS-1619, to assess their effects on channel function.

Main Results:

  • MTX caused a minimal shift in steady-state activation of BK channels in native parotid acinar cells (6 mV), contrasting with large shifts in heterologously expressed channels (70 mV).
  • Despite minimal steady-state effects, MTX approximately doubled the gating kinetics of BK channels in parotid cells.
  • The accessory protein LRRC26, expressed in parotid glands, rendered parSlo BK channels resistant to MTX activation but had minimal impact on NS-1619 efficacy.
  • Parotid BK channels exhibit a more hyperpolarized voltage activation range, potentially due to LRRC26.

Conclusions:

  • The accessory protein LRRC26 selectively alters the pharmacology of large conductance calcium-activated potassium channels.
  • LRRC26 confers resistance to MTX activation while largely preserving sensitivity to benzimidazolone activators like NS-1619.
  • These findings highlight the crucial role of accessory proteins in fine-tuning BK channel function and drug response in native tissues.

Related Concept Videos

Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
The Two-State Receptor Model01:29

The Two-State Receptor Model

The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...